The Effect of a Probiotic Strain on Ibuprofen-induced GI Damage

Completed · Not applicable · Has a placebo group

Conditions studied: Reduction of Small Intestinal Ulceration Risk

In brief

To investigate if a daily dose of minimum 15 billion CFU of Bif195 reduces the risk of small-intestinal tissue damage in an Ibuprofen challenge model as assessed by video capsule endoscopy in a healthy US population.

Key facts

Study ID

NCT04447924

Run by

Chr Hansen

People needed

177

Starts

2020-06-22

Expected to finish

2021-06-10

Last updated by the study team

2021-08-26

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Written informed consent
• Healthy and without any gastrointestinal pain or other significant symptoms
• Age 18 - 40 years
• Willing to abstain from any other probiotic products and/or medication known to alter gastrointestinal function throughout the participation of the trial

Where it is running

• Atlantia Food Clinical Trials — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.